Polyamines Are Present in Mast Cell Secretory Granules and Are Important for Granule Homeostasis by García-Faroldi, Gianni et al.
Polyamines Are Present in Mast Cell Secretory Granules
and Are Important for Granule Homeostasis
Gianni Garcı ´a-Faroldi
1, Carlos E. Rodrı ´guez
1, Jose ´ L. Urdiales
1, Jose ´ M. Pe ´rez-Pomares
2, Jose ´ C. Da ´vila
3,
Gunnar Pejler
4, Francisca Sa ´nchez-Jime ´nez
1, Ignacio Fajardo
1*
1Department of Molecular Biology and Biochemistry, and CIBER de Enfermedades Raras (CIBER-ER), Faculty of Sciences, University of Ma ´laga, Ma ´laga, Spain,
2Department of Animal Biology, Faculty of Sciences, University of Ma ´laga, Ma ´laga, Spain, 3Department of Cell Biology, Genetics and Physiology, Faculty of Sciences,
University of Ma ´laga, Ma ´laga, Spain, 4Department of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, Uppsala Biomedical Centre
(BMC), Uppsala, Sweden
Abstract
Background: Mast cell secretory granules accommodate a large number of components, many of which interact with highly
sulfated serglycin proteoglycan (PG) present within the granules. Polyamines (putrescine, spermidine and spermine) are
absolutely required for the survival of the vast majority of living cells. Given the reported ability of polyamines to interact
with PGs, we investigated the possibility that polyamines may be components of mast cell secretory granules.
Methodology/Principal Findings: Spermidine was released by mouse bone marrow derived mast cells (BMMCs) after
degranulation induced by IgE/anti-IgE or calcium ionophore A23187. Additionally, both spermidine and spermine were
detected in isolated mouse mast cell granules. Further, depletion of polyamines by culturing BMMCs with a-
difluoromethylornithine (DFMO) caused aberrant secretory granule ultrastructure, impaired histamine storage, reduced
serotonin levels and increased b-hexosaminidase content. A proteomic approach revealed that DFMO-induced polyamine
depletion caused an alteration in the levels of a number of proteins, many of which are connected either with the regulated
exocytosis or with the endocytic system.
Conclusions/Significance: Taken together, our results show evidence that polyamines are present in mast cell secretory
granules and, furthermore, indicate an essential role of these polycations during the biogenesis and homeostasis of these
organelles.
Citation: Garcı ´a-Faroldi G, Rodrı ´guez CE, Urdiales JL, Pe ´rez-Pomares JM, Da ´vila JC, et al. (2010) Polyamines Are Present in Mast Cell Secretory Granules and Are
Important for Granule Homeostasis. PLoS ONE 5(11): e15071. doi:10.1371/journal.pone.0015071
Editor: David Holowka, Cornell University, United States of America
Received September 6, 2010; Accepted October 19, 2010; Published November 30, 2010
Copyright:  2010 Garcı ´a-Faroldi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants SAF2008-02522 (Ministerio de Ciencia e Innovacio ´n, Spain), P07-CVI-02999 and BIO-267 group (Junta de Andalucı ´a,
Spain) and funds provided by Fundacio ´n Ramo ´n Areces (Spain). It was also helped by the European Cooperation in Science and Technology (COST) Action
BM0806, supported by the European Union (EU) Framework Programme for Research and Technological Development (RTD). The CIBER-ER is an initiative of the
Instituto de Salud Carlos III (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ifajardo@uma.es
Introduction
Mast cells participate both in the innate and adaptive immune
response [1] and are thereby considered an important component
of the immune system. However, mast cells are best known for
their implication in a large number of physio-pathological
settings, including allergy, asthma, atherosclerosis, inflammatory
arthritis, multiple sclerosis and cancer [2–7]. The ability of mast
cells to take part in all of these processes is mainly attributable to
the release of a vast array of molecules (referred to as
inflammatory mediators). Among the inflammatory mediators
released by mast cells, many are preformed and stored in
secretory granules, and can be discharged upon exposure to a
number of different stimuli such as crosslinking of IgE bound to
the high affinity IgE receptor (FceRI) [8]. These mediators
include biogenic amines such as histamine and serotonin, several
mast cell-specific neutral proteases (mainly tryptases and
chymases) and cytokines [9]. In addition, essential components
of mast cell granules are proteoglycans (PGs), consisting of
protein cores to which unbranched, sulfated, and thereby
negatively charged polysaccharides of glycosaminoglycan type
are attached [8,10]. The PGs located in mast cell granules are
mainly of the serglycin type, and these exert a key role in
promoting the storage of numerous mediators, including
histamine, serotonin and several mast cell proteases [11–16].
Histamine and serotonin are 1,4/1,3-diamines synthesized by
amino acid decarboxylases. Other 1,4/1,3-amines are the
ornithine-derived polyamines (putrescine, spermidine and sperm-
ine), small polycations present in the majority of living organisms
where they are absolutely necessary for cell survival. To maintain
accurate intracellular concentrations of polyamines, a number of
metabolic enzymes and transporters act in concert. Among the
enzymes involved in polyamine biosynthesis, it is widely
recognized that ornithine decarboxylase (ODC; EC 4.1.1.17) is
the key component, its expression and activity being subject to an
extraordinary extent of regulation [17,18]. Polyamines have been
implicated in a large number of cellular processes, including
functioning of ion channels, nucleic acid packaging, DNA
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thought that the contribution of polyamines to these processes is
mainly explained by their ability to stabilize negatively charged
biomolecules such as nucleic acids, proteins and cell membranes
[17,18,20]. Additional negatively charged macromolecules with
the potential to interact with polyamines are the PGs. In fact, a
strong interaction of spermine with PGs containing glycosamino-
glycans of heparan sulphate/heparin type has been documented
[21]. Furthermore, the uptake of polyamines from the extracellular
medium depends on their interaction with surface heparan sulfate
PGs [22], and it has been demonstrated that glypican-1 is an
important PG species mediating this uptake in mammalian cells
[23].
Taking into account the established role of polyamines in the
packaging of negatively charged macromolecules such as DNA in
the nucleus, together with the known interaction of polyamines
with PGs, we hypothesized that polyamines might be present in
the PG-rich mast cell granules. Indeed, we here present evidence
that polyamines are associated with mast cell granules. Further-
more, we demonstrate that polyamines are important for the
correct biogenesis and homeostasis of mast cell secretory granules,
including proper storage of histamine.
Materials and Methods
Ethics statement
This research study was conducted according to regional and
national regulations (‘‘Decreto 142/2002’’ and ‘‘Real Decreto
1201/2005’’, respectively) and international guidelines (the
European Convention and the European Commissions Directive
86/609/EEC on protection of animals used for experimental and
other scientific purposes). The study was specifically approved by
the Experimentation Ethics Committee of the University of
Ma ´laga (CEUMA), Ma ´laga, Spain (procedure code 2009–0054).
Mice were kept according to standard routines at the University
Animal Center, and were sacrificed by cervical dislocation (a
method included in the procedure mentioned above) before
obtention of bone marrow derived mast cells (BMMCs).
Materials
Cell culture media, fetal bovine serum, antibiotics and L-
glutamine were purchased from BioWhittaker (Cambrex, UK).
Plastics for cell culture were supplied by NUNC (Roskilde,
Denmark). Polyclonal antibodies against mouse mast cell protease
(mMCP)-6 and mouse MC carboxypeptidase A (mMC-CPA) were
raised in rabbits [24,25]. Rabbit polyclonal antibodies against
mannose-6-phosphate receptor binding protein 1 (M6PRBP1) and
cytochrome C oxidase (COX)-IV were from Abcam (Cambridge,
UK). Rabbit polyclonal antibody against acetyl-histone H3 was
from Upstate (Temecula, CA, USA). Mouse monoclonal antibody
against b-actin (clone AC-15) was from Sigma-Aldrich (St. Louis,
Mo., USA). Monoclonal purified anti-TNP mouse IgE (clone C38-
2) and monoclonal purified rat anti-mouse IgE (clone R35-72)
were from BD Biosciences Pharmingen (USA). L-[U-
14C]histidine
(50 mCi/mL, .300 mCi/mmol) and Percoll were supplied by GE
Healthcare (Chalfont St. Giles, UK). a-Difluoromethylornithine
(DFMO) was a kind gift of Dr. Patrick Woster (Wayne State
University) who obtained it from Ilex Oncology (San Antonio,
Texas). Acetonitrile and methanol for HPLC were from Romil
(Teknokroma, Spain). All buffer salts and other chemicals were
purchased either from Merck (VWR International) or Sigma-
Aldrich.
Cell culture
BMMCs were obtained essentially as previously described [24].
Briefly, C57BL/6 mice (female, 9–11 weeks old) were sacrificed by
cervical dislocation (a method approved by the local ethics
committee as stated above), and femur and tibia bone marrow cells
were extracted and cultured at 37uC in a humidified atmosphere
containing 5% CO2 in 50% DMEM supplemented with 10%
heat-inactivated fetal bovine serum, 50 mg/mL gentamycin
sulphate and 2 mM L-glutamine and 50% WEHI-3B conditioned
medium (as a source of IL-3). The cells were kept at a density of
0.5610
6 cells/mL, and the culture medium was changed every
third day. Mast cell differentiation and maturation was judged by
either toluidine blue or May-Gru ¨nwald/Giemsa staining, FceRI
and CD117 (c-kit) surface expression, histamine content, mMCP-6
expression and the ability of the cells to degranulate upon
stimulation with IgE/anti-IgE. Unless otherwise indicated, all the
experiments carried out in the present study were conducted with
3 weeks old BMMCs, where the cell population consisted of more
than 90% mast cells. In some experiments, BMMCs were
obtained in the presence of DFMO, a treatment used to cause a
depletion in polyamines. In this case, bone marrow cells were
extracted and cultured as mentioned above and, on day 4, 5 mM
DFMO was added to the cell culture medium and maintained for
the rest of the culture time. As a control for the effects observed
upon addition of DFMO, in some experiments cells were also
grown in the presence of DFMO and 100 mM putrescine. This
concentration of putrescine was determined as being the optimal
in restoring spermidine levels to similar values to those of
untreated control cells.
WEHI-3B-conditioned medium was produced by seeding
WEHI-3B cells (0.5610
6 cells/mL) into the medium described
above and incubating them for 3 days.
Cell staining
Cells were cytospun onto slides and stained using a modified
May-Gru ¨nwald/Giemsa protocol. Briefly, after fixation in meth-
anol for 3 min, slides were stained for 5 min in May-Gru ¨nwald
(Fluka), 1 min in 1:1 dilution of May-Gru ¨nwald and 15 min in
Giemsa (Fluka). Slides were washed in H2O and mounted with
DPX solution.
Granule preparation
Mast cell granules were isolated according to the method of
Kru ¨ger et al. [26] with some modifications. The cells were
resuspended in ice-cold balanced salt solution (BSS; 4 mM
Na2HPO4, 2.7 mM KH2PO4, 150 mM NaCl, 2.7 mM KCl,
0.9 mM CaCl2, pH 7.2) supplemented with 0.175% bovine serum
albumin (BSSA) at a cell density of 2–3610
6 cells/mL. Aliquots of
2.5 mL in 156100 mm glass tubes were sonicated at 4uC in a bath
sonicator (Selecta Ultrasons, JP Selecta, Spain) during 20 s.
Sonicates were pooled and centrifuged at 200 g for 5 min at
4uC. The supernatant, containing the granules, was decanted and
maintained at 4uC. The pellet, containing cellular debris and non-
broken cells, was resuspended in BSSA, resonicated and
centrifuged at 200 g for 5 min at 4uC. The resulting supernatant
was combined with that obtained after the first round of
sonication, and the complete suspension was then centrifuged at
2100 g for 20 min at 4uC. The resulting pellet, consisting of a
crude granule fraction, was gently resuspended in 0.5 mL of ice-
cold BSSA per 5–6610
6 original mast cells. The 0.5 mL was then
layered on top of 2.5 mL of 90% Percoll solution, containing
150 mM NaCl, 2.7 mM KCl, 0,9 mM CaCl2 and 10 mM
HEPES, and adjusted to a final pH of 7.2. Centrifugation was
performed at 27,000 g for 20 min (Beckman Optima XL-90
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centrifugation, one single band containing the granules was
obtained. This granule fraction was carefully collected and Percoll
was removed by centrifugation at 100,000 g for 1 h at 4uC.
Finally, the granules fraction was washed twice with ice-cold
BSSA, immediately frozen with liquid nitrogen and stored at
280uC until analysis.
Degranulation assay
Cells were stimulated to degranulate by two independent
protocols, i.e. exposure to IgE/anti-IgE or to calcium ionophore
A23187. For the IgE/anti-IgE protocol, cells (4610
6/mL) were
preloaded for 6 h with anti-TNP mouse IgE (1 mg/mL) in
medium. Next, sensitized cells were washed with phosphate
buffered saline (PBS; 10 mM phosphate, 137 mM NaCl,
2.68 mM KCl (pH 7.4)), placed in Tyrode’s buffer (10 mM
HEPES, 130 mM NaCl, 5 mM KCl, 1.4 mM CaCl2,1 m M
MgCl2, 5.6 mM glucose, 0.1% (w/v) BSA, (pH 7.4)) at 4610
6/mL
and stimulated with anti-mouse IgE (2 mg/mL) for 1 h. Stimula-
tion with calcium ionophore A23187 was performed by treating
the cells (4610
6/mL) with A23187 at a final concentration of
2 mM during 2 h in Tyrode’s buffer. As a control, cells incubated
during 2 h in Tyrode’s buffer were used. To evaluate the extent of
degranulation, the enzymatic activity of b-hexosaminidase in
supernatants and cell pellets was measured as described in the next
section.
Hexosaminidase activity
b-hexosaminidase activity was assayed as an evaluation of the
extent of degranulation following stimulation of cells under
different treatments with IgE/anti-IgE or A23187, and also as
an estimation of the intracellular and extracellular content of this
enzyme in cell cultures under different treatments.
In the first case, after degranulation, the enzymatic activity of b-
hexosaminidase in supernatants and cell pellets solubilized with
1% (v/v) Triton-X-100 in Tyrode’s buffer was measured with p-
nitrophenyl N-acetyl-b-D-glucosaminide in 0.05 M citric acid
(pH 4.5) for 60 min at 37uC. The reaction was stopped by the
addition of 0.05 M Na2CO3 (pH 10.7), and the release of the
product p-nitrophenol was detected by absorbance at 405 nm.
The extent of degranulation was estimated by calculating the
percentage of p-nitrophenol absorbance in the supernatant versus
total absorbance (supernatant + cell pellet solubilized in detergent).
To determine the intracellular and extracellular content of b-
hexosaminidase in cell cultures (i.e. cells not stimulated for
degranulation) we followed the assay described by Riederer et al.
[27] with minor modifications. Briefly, 18-days old BMMCs were
washed with PBS and resuspended in culture medium lacking
phenol red. On day 21, secreted hexosaminidase activity was
assayed in 0.5 mL media by addition of 125 mL 5 X hexosamin-
idase substrate buffer (0.5 M sodium acetate pH 4.4, 0.5% Triton-
X-100, 5 mM p-nitrophenyl N-acetyl-b-D-glucosaminide). After
1 h at 37uC, reactions were stopped by addition of 0.6 mL of
0.5 M glycine, 0.5 M Na2CO3, pH 10. Release of p-nitrophenol
was measured spectrophotometrically at 405 nm. One U of
enzyme activity was defined as the amount of enzyme needed to
hydrolyze 1 nmol per hour at 37uC. For intracellular hexosamin-
idase determination cells (3610
6) were lysed in 500 mLo f1 0m M
phosphate buffer pH 6, 150 mM NaCl, 0.5% Triton-X-100 and
the lysate centrifuged at 100,000 g for 10 min at 4uC. Afterwards,
the supernatant was recovered, further diluted (1/10) with the
same buffer and the activity was assayed following the same
procedure described above by mixing 50 mL with 575 mL of 1.1 X
hexosaminidase substrate buffer.
Amine determination
The intracellular content of putrescine, histamine, serotonin,
spermidine and spermine was simultaneously determined by
fluorimetry after separation of their dansyl derivatives by
reversed-phase HPLC as previously described [28]. Amines in
isolated mast cell granules were assayed by this method as well. In
some experiments, extracellular contents of amines after cell
degranulation (in Tyrode’s buffer) were also determined by this
HPLC method. Histamine and serotonin quantification in cell
culture supernatants was performed by ELISA with the use of
EIA-4616 (DRG, Germany) and ultrasensitive EIA BA10-5900
(Labor Diagnostika Nord, Nordhorn, Germany), respectively.
Results were normalized to cellular numbers and are expressed as
nmol of each amine/10
6 cells.
Transmission electron microscopy
Cells were fixed in 2% glutaraldehyde in 0.1 M cacodylate
buffer, pH 7.2, supplemented with 0.1 M sucrose for 10 h. Cells
were post-fixed in 1% osmium tetroxide in the same buffer for
90 min, dehydrated in graded series of ethanol and embedded
with epoxy plastic Agar 100 (Agar Aids, Stansted, UK). Ultrathin
sections were placed on Formvar-coated copper grids and
constrated with 2% uranyl acetate and Reynolds Lead citrate.
Analysis was performed in a Hitachi Electron Microscope at
75 kV. Ultrastructural features were observed in at least 200 cells.
Western blot analysis
Protein expression levels for mMCP-6, mMC-CPA, acetyl-
histone H3, COX-IV and M6PRBP1 were assayed by Western
blot as described previously [28]. Primary antibodies were used at
a dilution of 1:2000 (anti-mMCP-6 and anti-mMC-CPA), 1:1000
(anti-COX-IV and anti-M6PRBP1) and 1:5000 (anti-acetyl-
histone H3), and secundary antibody (HRP-conjugated anti-rabbit
IgG; GE Healthcare) at 1:5000. Normalization for sample loads
was performed by re-probing membranes with the anti b-actin
mouse monoclonal antibody described above.
Histidine decarboxylase activity
Histidine decarboxylase (HDC) enzymatic activity was mea-
sured by following the release of
14CO2 from L-[
14C]-labeled
histidine as we have previously described [29]. Results are
expressed as pmol of CO2 released/h/10
6 cells.
Total RNA isolation and quantitative PCR
Total RNA was isolated (4610
6 cells per extraction) following
the protocol provided with the GenElute Mammalian Total RNA
Miniprep Kit (Sigma-Aldrich) according to manufacturer instruc-
tions. RNA yield and purity were assessed spectrophotometrically
at 260 and 280 nm, and only highly purified RNA (A
260/A
280
.1.95) was used. One microgram of RNA was treated with RNase
free DNase (Promega, USA) and then reverse-transcribed using
the iScript cDNA Synthesis Kit (Bio-Rad, USA) according to the
recommendations of the manufacturers.
Quantitative PCR (qPCR) was performed in a final volumen of
25 mL, containing 1 mM of both primers, 1x SYBR Green
supermix (Bio-Rad), and 1.5 mL of cDNA using Mx3000P
machine (Stratagene, USA). The program profile used for all
genes amplification was: 95uC for 10 minutes and 40 cycles of 20
seconds at 95uC, 15 seconds at 55uC and 30 seconds at 72uC. Plate
reading was performed after each cycle. A melting curve was
generated at the end of every run to ensure product uniformity.
Hypoxanthine guanine phosphoribosyl transferase (HPRT) and
beta-actin (ACTB) were used as housekeeping genes to compen-
Polyamines and Mast Cell Granules
PLoS ONE | www.plosone.org 3 November 2010 | Volume 5 | Issue 11 | e15071sate for differences in cDNA amount of M6PRBP1 between
samples. The method used to calculate the relative amount of
cDNA was described by Liu and Saint [30], and the relative
efficiencies for individual amplification were calculated using the
LinRegPCR program [31].
Primers sequences for M6PRBP1 and ACTB were obtained from
the PrimerBank database [32] and were as follows: M6PRBP1
forward, 59-ATGTCTAGCAATGGTACAGATGC-39;M 6 P R B P 1
reverse, 59-CGTGGAACTGATAAGAGGCAGG-39; ACTB for-
ward, 59-GGCTGTATTCCCCTCCATCG-39;A C T Br e v e r s e ,5 9-
CCAGTTGGTAACAATGCCATGT-39. Primers for HPRT were
those used in a previous study [14] and were: HPRT forward, 59-
GATTAGCGATGATGAACCAGGTTA-39; HPRT reverse, 59-
GACATCTCGAGCAAGTCTTTCAGTC-39.
Sample preparation for proteomic analysis, 2-D
electrophoresis and protein identification
In brief (for complete description see Supplemental Data S1):
for each sample, 20610
6 cells were lysed directly in 500 mLo f
10% (w/v) TCA in acetone supplemented with 20 mM DTT, and
proteins were allowed to precipitate for 1 h at 220uC. Next,
samples were centrifuged for 10 min at 15,000 g at 4uC, and
protein pellets were washed twice with acetone supplemented with
20 mM DTT and allowed to air dry. Subsequently, proteins were
dissolved in 450 mL of rehydration solution at RT. Samples were
clarified by centrifugation for 1 min at 15,000 g and were then
applied to nonlinear pH 3–10 immobilized pH gradient strips.
Next, isoelectric focusing was performed, and strips were then
equilibrated for 15 min in SDS-equilibration buffer supplemented
with 1% (w/v) DTT and for another 15 min with SDS-
equilibration buffer supplemented with 2.5% (w/v) iodoacetamide.
After equilibration, strips were applied to 10% SDS-PAGE gels.
Electrophoresis was carried out at 2.5 W per gel during the first
30 min followed by 17 W per gel until complete. Proteins in the
gels were fixed and stained using the silver staining procedure as
described by Shevchenko et al. [33] and were stored at 4uCi n2 %
(v/v) acetic acid until mass spectrometry (MS) analysis. For gel-
image analysis, gels were scanned at high resolution with a
calibrated densitometer model GS-800 (Bio-Rad), and the
PDQuest version 7.4 software (Bio-Rad) was used for detection
of qualitative and quantitative alterations in protein spots. Spots of
interest were excised from the gels, washed twice with water and
were in-gel digested with porcine trypsin (Promega, Madison, WI)
in essence as described by Shevchenko et al. [33]. The generated
peptides were analyzed by MS using a 4700 MALDI-TOF/TOF
mass spectrometer (Applied Biosystems, Foster City, CA). Protein
identification was achieved by a combined strategy consisting of a
peptide mass fingerprinting (PMF) search plus the MS/MS search
of up to five peptide ions. Searches were performed using GPS
Explorer
TM software v 3.5 (Applied Biosystems) in non-redundant
NCBI database of proteins using MASCOT searching engine
(Matrix Science Ltd., London; http://www.matrixscience.com).
Digestion of proteins in the spots, MS and PMF searches were
performed either by the Proteomics Unit, SCAI, University of
Co ´rdoba, or by the Unidad de Proteo ´mica, Edificio de
Bioinnovacio ´n, University of Ma ´laga.
Statistical analysis
Statistical significance for amine determinations, HDC activity
and b-hexosaminidase activity analysis was determined by the
Student’s paired samples t-test (two-tailed) using the GraphPad
software. Values of P,0.05 were considered to be significant.
Results
Release of spermidine upon mast cell degranulation
To address the possibility that polyamines are associated with
mast cell secretory granules, we first investigated if polyamines are
released upon mast cell degranulation. Three weeks-old BMMCs
were induced to degranulate by using two independent stimuli,
treatment with IgE/anti-IgE or with calcium ionophore A23187.
As shown in Fig. 1, both treatments induced the cells to
degranulate, as judged by the reduced intracellular and increased
extracellular b-hexosaminidase activity after addition of IgE/anti-
IgE or A23187. The extent of degranulation calculated with
respect to non-stimulated cells was about 30 and 40%,
respectively, both values consistent with previous studies [13,34].
Determination of biogenic amines both in the supernatants and
cell pellets confirmed degranulation, as evidenced by the detection
of histamine and serotonin in the supernatants (Fig. 2D and 2F) at
the expense of a reduction of their corresponding intracellular
levels (Fig. 2, compare 2C and 2E with 2A). In addition, a small
but clearly distinguishable peak corresponding to spermidine was
detected in the supernatants after both IgE/anti-IgE and calcium
ionophore A23187 treatments (Fig. 2D and 2F), indicating release
of this polyamine upon mast cell degranulation. Importantly, the
magnitude of release of the different biogenic amines, including
spermidine, was consistent with that of b-hexosaminidase
(compare Fig. 2 with Fig. 1), with the stimulation by calcium
ionophore A23187 being more effective than with IgE/anti-IgE.
Detection of polyamines in isolated mast cell granules
The release of spermidine upon mast cell degranulation
supports the hypothesis that polyamines, at least spermidine, are
associated with mast cell granules. To test this hypothesis further,
we sought polyamines in isolated mast cell granules. Intact mast
cell granules, i.e. membrane-bound secretory granules, have been
isolated previously for different purposes from rat peritoneal mast
cells [35–37] by using the method described by Kru ¨ger et al. [26].
Since, to the best of our knowledge, there is no specific procedure
Figure 1. Activation and degranulation of BMMCs. Bone marrow
precursor cells were cultured in vitro into BMMCs as described in
Experimental Procedures. Cells (4610
6/mL) were stimulated to degran-
ulate by exposure to IgE/anti-IgE or to calcium ionophore A23187 as
described in Experimental Procedures. As a control, cells incubated
during 2 h in Tyrode’s buffer were used. Degranulation extent was
monitored by determining the b-hexosaminidase activity in the cell
pellets and supernatants, as described in Experimental Procedures.
Results are expressed as percentages of total b-hexosaminidase activity
and are means 6 SEM of four independent experiments. *P,0.05
compared with control by Student’s paired sample t-test (two-tailed).
doi:10.1371/journal.pone.0015071.g001
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used this method. Briefly, the method involves mild sonication of
the cells followed by a low-speed centrifugation to remove cell
debris, and a final purification of the granules using a Percoll
density gradient. Typically, when rat peritoneal mast cells are used
as starting material, two distinct bands are obtained after the
Figure 2. Intracellular and extracellular biogenic amines in BMMCs after degranulation. Bone marrow precursor cells were cultured in
vitro into BMMCs as described in Experimental Procedures. Cells (4610
6/mL) were stimulated to degranulate by exposure to IgE/anti-IgE (C, D) or to
calcium ionophore A23187 (E, F) as described in Experimental Procedures. As a control, cells incubated during 2 h in Tyrode’s buffer were used (A, B).
Amines were assayed in cell pellets (A, C, E) and supernatans (B, D, F) by HPLC as described in Experimental Procedures. Results shown are
representative of three independent experiments. Put, putrescine; Hia, histamine; 5-HT, serotonin; 1,8-DO, 1,8-diaminooctane; Spd, spermidine; Spm,
spermine.
doi:10.1371/journal.pone.0015071.g002
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membrane-free granules and a lower band containing intact
membrane-bound granules [26]. When applying this method to
BMMCs, only a single band was obtained (not shown), most
probably consisting of both intact and membrane-free granules.
This fraction was carefully recovered and washed twice before
further analysis, to eliminate any component not tightly bound. As
shown in Fig. 3, the recovered fraction indeed contained mast cell
secretory granules, as evidenced by the detection of tryptase
mMCP-6, histamine and serotonin. Further, this fraction was free
from major putative contaminations with other organelles, as we
were unable to detect COX-IV or acetyl-histone H3, specific
markers for mitochondrion and nucleus, respectively. Finally, and
more striking, we detected a clear peak corresponding to
spermidine and a weaker but discernible peak corresponding to
spermine in the isolated granule fraction (Fig. 3B).
Polyamine depletion leads to altered ultrastructure of
mast cell granules
The previous results are compatible with the presence of
polyamines in the mast cell granules, and we next investigated
whether a depletion of polyamines may provoke any alteration in
the morphology/appearance of mast cell granules. Polyamine
depletion may be achieved by using DFMO, an irreversible
inhibitor of ODC [38]. In a recent study we treated BMMCs with
DFMO and obtained a large general reduction of both putrescine
and spermidine [28], an effect in line with other works [39].
However, the possibility that polyamines are present in the mast
cell secretory granules and the potential impact of polyamine
presence on granule homeostasis has not been addressed
previously. To specifically address these issues, BMMCs were
generated in the presence of DFMO and cell morphology was
analyzed by May-Gru ¨nwald/Giemsa staining and by transmission
electron microscopy. Similarly to our previous study, an
assessment of intracellular amine levels confirmed a large
reduction of total polyamines after treatment with DFMO:
putrescine was undetectable after the treatment and spermidine
content was reduced by approximately 90% (Table 1). The
reduction of total polyamines did not provoke a major effect on
cell proliferation, a result not unexpected given the low
proliferation rate of BMMCs (population doubling time of more
than 4 days). Indeed, the cell numbers recorded prior to each
medium change were only slightly reduced for the treated cells as
compared with the untreated ones (not shown). As shown in
Fig. 4A and 4B, the May-Gru ¨nwald/Giemsa staining did not
reveal any major change in the staining properties of the granules
after treatment of the cells with DFMO. Both control and DFMO-
treated cells showed an abundance of densely stained secretory
granules, suggesting a normal PG content. Transmission electron
microscopy analysis, however, revealed striking differences in the
ultrastructure of secretory granules. While non-treated control
cells exhibited typical features of BMMC granules, i.e. a marked
formation of dense core structures interspersed by electron
translucent areas (Fig. 4C and in detail 4E), in DFMO-treated
cells approximately 40% of the cells showed evenly distributed,
amorphous material throughout the entire granules, without dense
core formation (Fig. 4D and 4F). To rule out putative non-specific
effects attributable to the inhibitor, a second control experiment
was performed where cells were treated with DFMO in the
presence of 100 mM putrescine, with the putrescine addition
serving to reverse the effect of DFMO. Amine analysis in these
cells demonstrated that, under these conditions, spermidine levels
were restored to similar values as those of untreated control cells
(Table 1). Moreover, an almost complete reversion of the effect
observed in DFMO-treated cells was obtained, with approximately
only a 7% of the cells showing the DFMO-induced phenotype (not
shown). Taken together, these results suggest that spermidine is
associated with mast cell granules, and indicate that polyamine
depletion modifies secretory granule ultrastructure, the latter
occurring without apparent alterations in the total PG content.
Furthermore, the results support the hypothesis that polyamines
are important for mast cell granule homeostasis.
Figure 3. Qualitative detection of polyamines in isolated mast cell granules. Bone marrow precursor cells were cultured in vitro into BMMCs
as described in Experimental Procedures and maintained until day 35. Granules were then isolated and detection of mMCP-6, COX-IV and acetyl-
histone H3 was performed in total cell lysates and in the granule fraction (A) by Western blot. Amines were assayed in the granule fraction (B) by
HPLC as described in Experimental Procedures. The chromatogram shown is representative of three independent experiments. Hia, histamine; 5-HT,
serotonin; 1,8-DO, 1,8-diaminooctane; Spd, spermidine; Spm, spermine.
doi:10.1371/journal.pone.0015071.g003
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Next, the effect of polyamine depletion on the storage of several
mast cell secretory granule components, i.e. histamine, serotonin,
mMCP-6, mMC-CPA and b-hexosaminidase was investigated. As
shown in Fig. 5A and 5B, the intracellular levels of both histamine
and serotonin were reduced by more than 40% after the DFMO
treatment. However, while the DFMO treatment caused a
substantial increase in extracellular histamine levels, resulting in
an elevation of total histamine levels (Fig. 5A), extracellular
serotonin levels were in contrast significantly decreased, leading to
a reduced total amount of serotonin (Fig. 5B). Importantly, the
observed effects were specifically attributable to the depletion of
polyamines, since the addition of putrescine to the DFMO-treated
cells reversed the effects (Fig. 5A and 5B). The reduced
intracellular histamine content together with its elevated extracel-
lular levels after the DFMO treatment, suggest an alteration of
histamine storage as a consequence of polyamine depletion. In
support of this hypothesis, histamine synthesis rate showed a slight
Table 1. Polyamine levels in BMMCs generated in the
absence or presence of DFMO or DFMO + putrescine.
Amine Control DFMO
DFMO +
putrescine
Putrescine 0.260.05 ND 3.5560.74*
Spermidine 0.3760.04 0.036 0.008** 0.4460.01
Spermine 0.4160.04 0.4160.04 0.3360.04
Bone marrow precursor cells were cultured in vitro into BMMCs as described in
Experimental Procedures section. On day 4, 5 mM DFMO or 5 mM DFMO +
100 mM putrescine was incorporated or not (control) into the culture medium
and maintained for the rest of the culture time. After 3 weeks, intracellular levels
of polyamines were determined by HPLC as described in Experimental
Procedures section. Results are expressed as nmol/10
6 cells and are means 6
SEM of at least three independent experiments.
*P,0.05;
**P,0.001 compared with untreated control cells by Student’s paired sample t-
test (two-tailed). ND: non detected.
doi:10.1371/journal.pone.0015071.t001
Figure 4. Secretory granule morphology of BMMCs generated in the absence or presence of DFMO. Bone marrow precursor cells were
cultured in vitro into BMMCs as described in Experimental Procedures. On day 4, 5 mM DFMO was added to the culture medium and maintained for
the rest of the culture time. After 3 weeks, untreated (A, C, E) or DFMO-treated (B, D, F) cells were examined by an optic microscope (May-Gru ¨nwald/
Giemsa staining; A, B) or by transmission electron microscopy (C, D and in larger magnification E, F), as described in Experimental Procedures.
Micrographs shown are representative from two independent experiments. Observe the abundance of densely stained secretory granules after May-
Gru ¨nwald/Giemsa staining for both control (A) and DFMO-treated (B) cells. Note the presence of dense core formation (arrows in C and E) and
electron translucent areas (arrowhead in E) in control cell granules. Note also that this subdivision is absent in granules of DFMO-treated cells, which
instead contain evenly distributed, amorphous material throughout the entire granules, without dense core formation (arrowheads in D and F).
Magnification: A, B, 950 x; C, D, 9,000 x; E, F, 27,900 x.
doi:10.1371/journal.pone.0015071.g004
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PLoS ONE | www.plosone.org 7 November 2010 | Volume 5 | Issue 11 | e15071Figure 5. Effect of polyamine depletion on secretory granule component levels and degranulation ability in BMMCs. Bone marrow
precursor cells were cultured in vitro into BMMCs as described in Experimental Procedures. On day 4, 5 mM DFMO or 5 mM DFMO + 100 mM
putrescine was incorporated or not (control) into the culture medium and maintained for the rest of the culture time. After 3 weeks, intracellular
levels of histamine (A) and serotonin (B) corresponding to 4610
6 cells were analyzed by HPLC. Extracellular levels of histamine (A) and serotonin (B)
were assayed in cell culture media by ELISA. Protein levels for mMCP-6 (C) and mMC-CPA (D) were analyzed by Western blot (b-actin was used as a
control of sample loads). Both intracellular and extracellular b-hexosaminidase content (E) and % release after the indicated conditions (F) were
assayed as described in Experimental Procedures. The results displayed in A and B are means 6 SEM of at least three independent experiments. The
% of both intracellular and extracellular levels of each amine, calculated with respect to total values, are indicated beneath each corresponding plot
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statistically significant (HDC enzymatic activity in pmol/h/10
6
cells: control 8.3161,76 versus DFMO 12.861.3; P=0.24). On the
contrary, the observed simultaneous reduction of both intracellular
and extracellular levels of serotonin after the DFMO treatment,
with an unchanged intracellular/extracellular ratio for the levels of
this amine (see Fig. 5B), suggests that the DFMO treatment may
lead to either a decreased synthesis or increased degradation of this
amine, rather to an effect on the storage.
As shown in Fig. 5C and 5D, mMCP-6 and mMC-CPA protein
levels showed only a mild trend to increase after the DFMO
treatment. On the other hand, intracellular levels for the hydrolase
b-hexosaminidase were substantially increased (Fig. 5E), an effect
reversed with the addition of putrescine. Extracellular levels of this
enzyme did not change after the DFMO treatment but, curiously,
was significantly reduced upon addition of putrescine.
Finally, to investigate the possibility that polyamine depletion
provokes any effect on the ability of the cells to degranulate, we
analyzed the extent of degranulation after the DFMO treatment.
However, the addition of DFMO did not affect the amount of b-
hexosaminidase release in response to either IgE/anti-IgE or
calcium ionophore A23187 (Fig. 5F), indicating that granule-
contained polyamines do not influence the ability of BMMCs to
undergo degranulation.
Proteomic analysis
The results described above indicate that spermidine and
spermine are associated with mast cell granules. Moreover, our
data indicate that BMMCs with reduced total polyamine content
exhibit aberrant secretory granules, accompanied by defective
storage of histamine, decreased levels of serotonin and an
increased content of b-hexosaminidase. To provide insight into
the mechanisms underlying these observed effects, we explored
putative proteins whose expression may be altered as a
consequence of polyamine depletion. Proteins were separated by
2-D gel electrophoresis and the protein maps obtained were
analyzed. Preliminary assays were conducted to determine the
optimal experimental conditions for protein extraction from
BMMCs and subsequent 2-D gel electrophoresis. Three different
methods for protein extraction were tested: (i) use of the detergent
CHAPS alone, (ii) CHAPS in combination with urea, and (iii)
direct precipitation of proteins with TCA/acetone. The latter
method proved to be the most adequate (see Supplemental Data
S1, Fig. S1 and Table S1). Six samples corresponding to six
independent BMMC cultures (3 controls and 3 DFMO-treated)
were separated in 2-D gels (one sample per gel) and analyzed for
protein spot differences. In general, protein patterns were very
similar in all 6 gels obtained (not shown). However, a close image
analysis revealed a number of protein spots whose intensities were
remarkably changed after the DFMO treatment, and these were
selected for protein identification by MS. Representative gels for
both control and DFMO-treated cells are shown in Fig. 6, and
proteins identified in the selected spots are listed in Table 2. In the
majority of these cases, the DFMO treatment caused a markedly
reduced intensity of the respective spot, with the exception of one
spot, whose intensity was increased upon DFMO treatment.
From Table 2 it is apparent that several of the proteins whose
expression were altered upon polyamine depletion are involved in
glucose metabolism: pyruvate kinase M2 (PKM2), glycerol
phosphate dehydrogenase (GPDH-M) and phosphoenolpyruvate
carboxykinase (PEPCK-M). We also detected a reduction in the
levels of catalase, one of the major components that prevent the
harmful effect of reactive oxygen species. There was also a
downregulation of two proteins implicated as transcriptional
repressors: heterogeneous nuclear ribonucleoprotein A/B (hnRNP
A/B) and splicing factor 1 (mZFM). Two proteins with a structural
or scaffold role that aid different functions including endocytic
traffic and signal transduction, i.e. Na
+/H
+ exchange regulatory
cofactor NHE-RF1 (NHERF-1) and major vault protein (MVP),
were also decreased in samples corresponding to DFMO-treated
cells. In addition, two proteins related to cell cytoskeleton
remodeling, i.e. dihydropyrimidinase-related protein 2 (DRP-2)
and WD repeat-containing protein 1 (AIP-1), were downregulated.
Finally, and most striking, the DFMO treatment caused a
downregulation of M6PRBP1, a protein clearly implicated in
secretory granule formation. Proteins corresponding to spots
no. 12 and 13, detected only in control cells, were not identified.
Based on the strong implication of M6PRBP1 in secretory
granule formation, we validated its downregulation by an
independent technique, i.e. by Western blot analysis. As shown
in Fig. 7, protein levels for M6PRBP1 were drastically reduced in
DFMO-treated cells, and this effect was polyamine-depletion
specific as evidenced by the reversion of the DFMO effect caused
by the addition of putrescine. In contrast, the levels of M6PRBP1-
mRNA, as determined by quantitative RT-PCR, were not altered
(not shown), indicating a post-transcriptional effect of DFMO-
induced polyamine depletion on the expression of this protein.
Discussion
Formation of mast cell secretory granules is a highly complex
process absolutely essential for proper function of this cell type.
Mast cell secretory granules contain, in addition to histamine/
serotonin, cytokines, mast cell-specific proteases and serglycin PGs,
also a large number of lysosomal enzymes. Therefore, these
organelles have been termed ‘‘secretory lysosomes’’ [40]. The
biogenesis of this subcellular compartment is dependent on the
concerted contribution of both the exocytic and endocytic systems,
with an array of signals that mediate the correct protein sorting to
these organelles [41], many of which remain still unknown. In this
process, serglycin PGs are of major importance, providing the
skeleton necessary for the tight packaging of many compounds
within the secretory granules [11,16,42]. Because polyamines have
been described to aid the native conformation and packaging of
other anionic biopolymers such as different RNAs and also DNA
in the nucleus [17], and have been demonstrated to strongly
interact with PGs [21], we undertook this study to address the
possibility that polyamines are present in mast cell secretory
granules, possibly interacting with granule PGs and thereby having
a role in packaging the array of molecules that reside in these
organelles.
The release of spermidine together with histamine and
serotonin after triggering degranulation of BMMCs with either
IgE/anti-IgE or A23187 calcium ionophore, provided the first
evidence that polyamines, at least spermidine, are associated with
the mast cell secretory granules. A second and more conclusive
evidence was the detection of both spermidine and spermine in
isolated mast cell granules. In addition, subsequent experiments
showing profound alterations in the ultrastructure of BMMC
granules as a consequence of polyamine depletion with DFMO,
in A and B. Western blots shown are from representative experiments. Results displayed in E and F are means 6 SEM of three independent
experiments. *P,0.03; **P=0.06 compared with untreated control cells by Student’s paired sample t-test (two-tailed).
doi:10.1371/journal.pone.0015071.g005
Polyamines and Mast Cell Granules
PLoS ONE | www.plosone.org 9 November 2010 | Volume 5 | Issue 11 | e15071Figure 6. Representative 2D-gels for BMMCs generated in the absence or presence of DFMO. Bone marrow precursor cells were cultured
in vitro into BMMCs as described in Experimental Procedures. On day 4, 5 mM DFMO was incorporated into the culture medium and maintained for
the rest of the culture time. After 3 weeks, cells (20610
6) were taken and their proteins were extracted and separated by two-dimensional gel
electrophoresis, as described in Experimental Procedures. Representative gels for untreated control BMMCs (A) and DFMO-treated BMMCs (B) are
shown. Spots of interest are enclosed in circles and are numbered for their identification in Table 2. Magnification of the spots of interest are showed
on the right. Discontinue-line circles indicate the putative position for spots whose detection was not achieved in gels corresponding to DFMO-
treated cells. The position of the molecular weight standards is indicated at the left of each gel; the pH range is indicated at the top.
doi:10.1371/journal.pone.0015071.g006
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suggest that these polycations are important for the correct
biogenesis of these organelles. Secretory granules of BMMCs are
typically organized into electron dense ‘‘core’’ regions interspersed
by electron translucent areas and it was previously shown that the
absence of serglycin PG led to impaired dense core formation,
accompanied by a granule morphology with amorphous granule
content [13]. Hence, serglycin holds a key role in the assembly of
granule dense core material and this has proven vital for proper
storage of a number of secretory granule compounds [11,12,14].
Interestingly, we here demonstrate that depletion of polyamines by
treatment of BMMCs with DFMO causes a granule morphology
that closely resembles that of serglycin-deficient granules [13,43].
A likely explanation for this finding would be that DFMO
treatment causes a reduction in the amount of serglycin PG
present in the granules. However, staining of the BMMCs with
May-Gru ¨nwald/Giemsa, a dye that preferentially stains for highly
negatively charged PGs such as serglycin, did not reveal any
reduction in staining properties following DFMO treatment,
suggesting that DFMO does not act at the level of regulating
serglycin storage. Further, DFMO treatment did not lead to a
reduction in the storage of either MC-CPA or mMCP-6, granule
compounds that were previously shown to be strongly dependent
on serglycin for storage within the granules [11]. Thus, the most
likely explanation for the alterations in granule morphology is that
DFMO affects the process of dense core formation, independently
of direct effects on serglycin. We may therefore hypothesize that
optimal granule condensation in mast cells is a process that
requires the concerted action of both serglycin and polyamines. It
is important to note that the absence of serglycin does not seem to
affect the level of intracellular polyamines in MCs [14]. Hence,
Table 2. Identified proteins with altered expression levels in BMMCs generated in the presence of DFMO versus control BMMCs.
Spot No.
a Protein Name
b
Relative
expression
c
UniProtKB acc.
number Comments (www.uniprot.org)
1 Pyruvate kinase M2 (PKM2; fragment) q (3.8; P,0.01) P52480 Glycolysis
2 Glycerol-3-phosphate dehydrogenase 2,
mitochondrial (GPDH-M)
Q (5.2; P,0.01) A2AQR0 Gluconeogenesis
3 Phosphoenolpyruvate carboxykinase
[GTP], mitochondrial (PEPCK-M)
Q (7.1; P,0.02) Q8BH04 Gluconeogenesis
4 Catalase Q (4.2; P,0.01) P24270 Protection of cells from the toxic effects of hydrogen peroxide.
5 Heterogeneous nuclear ribonucleoprotein
A/B (hnRNP A/B)
- Q99020 Transcriptional repressor that binds to CArG box motifs, single-
stranded and double-stranded DNA, and RNA
6 Splicing factor 1 (mZFM) Q (3.0; P,0,01) Q64213 Necessary for the ATP-dependent first step of spliceosome
assembly. May act as transcription repressor
7N a ( +)/H(+) exchange regulatory
cofactor NHE-RF1 (NHERF-1 or EBP50)
Q (3.6; P,0.01) P70441 Scaffold protein that connects plasma membrane proteins with
members of the ezrin-radixin-moesin family and thereby helps to
link them to the actin cytoskeleton and to regulate their surface
expression.
8 Major vault protein (MVP) - Q9EQK5 Required for normal vault structure. Vaults are multi-subunit
structures that may act as scaffolds for proteins involved in signal
transduction.
9 Dihydropyrimidinase-related protein
2 (DRP-2)
- O08553 Necessary for signaling by class 3 semaphorins and subsequent
remodeling of the cytoskeleton. Plays a role in axon guidance,
neuronal growth cone collapse and cell migration
10 WD repeat-containing protein
1 (AIP-1)
Q (5.2; P,0.02) O88342 Induces disassembly of actin filaments in conjunction with ADF/
cofilin family proteins
11 Mannose-6-phosphate receptor binding
protein 1 (M6PRBP1 or TIP47)
Q (4.0; P,0.01) Q9DBG5 Transport of mannose 6-phosphate receptors (MPR) from
endosomes to the trans-Golgi network
a)Spot number as indicated in Fig. 6.
b)Protein identification was accomplished by a combined PMF and MS/MS strategy, as described in Materials and Methods Section. Detailed information concerning
searching results is provided in Table S2.
c)The minus sign (2) indicate absence of the corresponding protein spot in BMMCs generated in the presence of DFMO versus control BMMCs. Arrows (q/Q) indicate
statistically significant upregulation/downregulation of the corresponding protein spot in BMMCs generated in the presence of DFMO versus control BMMCs.
Quantitative changes, either increases or decreases, are indicated in parenthesis as well as the level of significance according to a Student’s t-test (fold; P value).
doi:10.1371/journal.pone.0015071.t002
Figure 7. M6PRBP1 protein levels in BMMCs generated in the
absence or presence of DFMO or DFMO + putrescine. Bone
marrow precursor cells were cultured in vitro into BMMCs as described
in Experimental Procedures. On day 4, 5 mM DFMO or 5 mM DFMO +
100 mM putrescine was incorporated or not (control) into the culture
medium and maintained for the rest of the culture time. After 3 weeks,
protein levels for M6PRBP1 were assayed in whole cell lysates by
Western blot as described in Experimental Procedures. b-actin was used
as a control of sample loads.
doi:10.1371/journal.pone.0015071.g007
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participate in maintaining granule homeostasis, polyamines and
serglycin are not mutually dependent on each other for storage.
A striking finding was that DFMO treatment caused a marked
reduction in the intracellular levels of histamine and serotonin. We
showed in a previous study that both of these compounds are
strongly dependent on serglycin for proper storage [14] and the
present work thus demonstrates that both of these additionally
require polyamines for maintenance of accurate intracellular
levels. In the case of serotonin, we observed a substantial reduction
of both the intracellular and extracellular levels, suggesting that the
DFMO treatment might be modifying the rate of synthesis or
degradation of this amine. By contrast, for histamine, the
intracellular levels were reduced and the extracellular levels were
increased, thereby indicating a diminished storage together with
an augmented secretion of this amine due to the DFMO
treatment. This conclusion is reinforced by the observed slight
trend of increased HDC enzymatic activity, an effect in line with a
previous recent study where we have described that the DFMO
treatment leads to increased histamine synthesis in the heteroge-
neous cell population that make up the IL-3-driven bone marrow
cell cultures after only 7 days [28].
Interestingly, DFMO treatment of the BMMCs also led to an
increase in the intracellular content of b-hexosaminidase, an
enzyme that was previously shown to be stored independently of
serglycin [13]. At this stage we cannot explain the mechanisms
behind this observation, although we may hypothesize that the
reduction in other granule compounds may facilitate the
accumulation of b-hexosaminidase. Alternatively, it cannot be
excluded that polyamines exert direct effects on b-hexosaminidase,
either by affecting the b-hexosaminidase protein content or by
influencing its enzymatic activity.
Together, these results thus suggest that polyamines cause
differential effects on individual mast cell granule components.
Given the possibility that the population of mast cell secretory
granules may be heterogeneous [41,44], it is conceivable that
polyamines cause distinctive effects on different subsets of granules.
In line with this notion, a recent report has described that the
antizyme inhibitor 2 (AZIN2; a protein that releases ODC from its
inactive complex with antizyme) is expressed in mast cells,
localizing in the serotonin-containing subset of granules (and not
in tryptase-containing granules), where the authors propose that it
could exert a role as a local regulator of polyamine biosynthesis, a
process required for serotonin release upon IgE-mediated
stimulation [45].
To gain insight into the mechanisms by which the depletion of
polyamines with DFMO results in the observed BMMC
phenotype, we conducted a proteomic analysis. We were able to
detect several protein spots that were altered upon DFMO
treatment. After MS identification, it is apparent that several of
these do not exhibit an obvious connection with the machinery
involved in the generation of mast cell secretory granules, e.g.
GPDH-M, PEPCK-M, PKM2, all of these being involved in
carbohydrate metabolism. Notably though, also previous work has
shown that depletion of polyamines with DFMO affects the levels
of enzymes involved in carbohydrate metabolism [46]. Also of
note, limited evidence suggests a connection between glucose
metabolism and the regulated exocytosis system: a reduced
glycolysis rate occurring upon mast cell degranulation, an effect
mediated by the ability of FcbRI to regulate PKM2 [47], and one
report describing an association between the protein levels of
PKM2 and annexin I and mast cell granule formation after
treatment with nerve growth factor [48].
More importantly, we detected DFMO-induced alterations in a
number of proteins that, because of their implication in either the
endocytic or exocytic systems, could be contributing to the
observed effects on granule storage/morphology. For example, we
detected a DFMO-induced reduction of NHERF-1 and MVP,
both proteins implicated in exo/endocytosis [49–54]. Also, we
detected alterations in AIP-1 and DRP-2, both being involved in
remodeling of the cytoskeleton. Indeed, the alteration of these
proteins may contribute to the observed granule effects, consid-
ering the importance of cortical actin cytoskeleton dynamics for
endocytic processes [55,56]. Finally, we also detected a consider-
able downregulation in the levels of M6PRBP1. Since this protein
plays a clear role in secretory granule formation, in particular as a
component of the molecular machinery that sorts many granule
compounds to the actual granules, its alteration could therefore
provide the best direction, as compared to the other proteins
detected, to further explore the mechanisms underlying the
observed DFMO-induced effects on granule storage/morphology.
Notably, several lysosomal hydrolases (including b-hexosamini-
dase) that are present both in conventional and secretory
lysosomes, are modified during their biosynthesis by the addition
of a M6P moiety. M6P is then recognized by M6PRs and these
transmembrane receptors cycle between the trans-Golgi network
(TGN) and late endosomes, targeting soluble proteins to
conventional and secretory lysosomes [40]. M6PRBP1 (also
known as TIP47) is one of the components responsible for the
recycling of M6PRs back to the TGN [57,58]. Conceivably, the
observed reduction of M6PRBP1 upon DFMO treatment could
thus impair M6PR-mediated targeting of granule compounds,
providing a partial explanation for the effects seen on granule
storage/morphology. Moreover, the observed alteration of b-
hexosaminidase activity could be considered as a consequence of
the impaired sorting of granule components. However, as
mentioned previously, we cannot rule out that the DFMO-
induced polyamine depletion alters either the b-hexosaminidase
protein content or its enzymatic activity.
It is remarkable that almost 50% of the proteins that were
reduced after DFMO treatment are implicated either in the
endocytic or the exocytic system, clearly in line with a role of
polyamines in regulating these processes. In support of this notion,
previous studies have revealed polyamine depletion-induced
effects related to these processes. For example, Hyvo ¨nen et al.
[59], in a model of acute pancreatitis provoked by catabolism-
induced polyamine depletion (i.e. by activation of polyamine
catabolism in rats overexpressing spermidine/spermine-N
1-ace-
tyltransferase) described important changes in the ultrastructure of
acinar cells, including the presence of early partially degranulated
zymogen granules. Furthermore, Kanerva et al. [60] have recently
described a critical role for AZIN2 in regulating the transport of
secretory vesicles by locally activating ODC and polyamine
biosynthesis. In this paper, the authors demonstrated selective
fragmentation of the TGN and retarded exocytotic release of
vesicular stomatitis virus glycoprotein upon RNAi-mediated
knockdown of AZIN2 or DFMO-induced cellular polyamine
depletion.
In summary, we here provide solid evidence that polyamines (i)
are associated with mast cell secretory granules, (ii) are important
for the correct maintenance of granule homeostasis (including
appropriate storage of histamine) and our results (iii) suggest an
important role for polyamines in regulating the complex
machinery that leads to the formation of these organelles.
Additionally, from a more general point of view, our findings
together with those of other authors support the hypothesis of a
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exocytosis and endocytosis.
Supporting Information
Figure S1 Representative 2D-gels after BMMCs protein
extraction using different methods. BMMC proteins were
extracted by the 3 procedures described in the Methods section,
and were subjected to 2D-electrophoresis. For each procedure
assayed, different amounts of proteins were tested (see Table S1).
Gels shown correspond approximately to 20610
6 cells and were
selected as being the best ones for each method as inferred in
Table S1. A: lysis solution with CHAPS, 1000 mg of proteins. B:
lysis solution with CHAPS + urea, 750 mg of proteins. C: proteins
corresponding to 20610
6 cells precipitated directly with TCA/
acetone. The position of the molecular weight standards is
indicated at the left of each gel; the pH range is indicated at the
top.
Table S1 Summary of the conditions used for the tested protein
extraction methods and results obtained.
Table S2 Information regarding mass spectrometry identifica-
tion of proteins in Table 2.
Data S1 Supplementary Material and Methods.
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